Log In
Monday 23rd April 2018

NICE rapped for drug restrictions

3rd August 2006

The National Institute for Health and Clinical Excellence (NICE) is under fire over its decisions to restrict a range of drugs used to treat Alzheimer’s disease.

NICE heard five appeals over two days from campaign groups and drug companies over limiting medicines for treating moderate stages of the condition.

The drugs include donepezil, rivastigmine, and galantamine, and memantine, which is not recommended for use outside clinical trials.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: NICE rapped for drug restrictions
Author: Chris May
Article Id: 600
Date Added: 3rd Aug 2006


BMJ News

Recent Related Articles

Energy drinks ban in the UK

Prescription drug addiction to be reviewed

Teachers diagnosed with mental health issues


Add to scrapbook
Show Comments
Add comment
Find all related articles


Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018